An increased understanding of the mechanism of action of steroid hormonal agents has transformed clinicians' ability to identify hormone-sensitive breast carcinoma. Furthermore, a new generation of hormonal agents has replaced the major surgical ablative procedures and the original additive hormonal agents used in the past.
No takes yet. Share an insight, caveat, or question.
Gabriel N. Hortobagyi (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: